International Multifoods Corporation

Bookmark

Add to MyYahoo RSS

International Multifoods Corporation News

News on International Multifoods Corporation (Ticker: LLY) continually updated from thousands of sources around the net.

Thursday Aug 28 | AmericanBankingNews.com

Eli Lilly and Receives Average Recommendation of "Buy" from Analysts

Eli Lilly and has received an average recommendation of "Buy" from the twenty-two analysts that are currently covering the stock, ARN reports .

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, Eli Lilly, Imclone Systems, Healthcare Industry

Wed Aug 27, 2014

AmericanBankingNews.com

Eli Lilly and Coverage Initiated by Analysts at Deutsche Bank

The firm set a "buy" rating on the stock. Several other analysts have also recently commented on the stock.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, Eli Lilly, Imclone Systems, Healthcare Industry

Tue Aug 12, 2014

AmericanBankingNews.com

Eli Lilly and Target of Unusually High Options Trading

Eli Lilly and was the target of some unusual options trading on Tuesday. Stock investors purchased 4,883 call options on the stock, StockRatingsNetwork reports.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, Eli Lilly, Imclone Systems, Healthcare Industry

Mon Aug 11, 2014

AmericanBankingNews.com

Eli Lilly and Price Target Cut to $61.00 by Analysts at Jefferies Group

Jefferies Group's price objective indicates a potential upside of 0.03% from the company's current price.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, Eli Lilly, Imclone Systems, Healthcare Industry

Wed Aug 06, 2014

AmericanBankingNews.com

Analysts' Recent Ratings Updates for Eli Lilly and

Eli Lilly and had its price target raised by analysts at Argus from $64.00 to $72.00.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Alnara Pharmaceuticals, Food, Avid Radiopharmaceuticals, Agriculture, Imclone Systems

Sat Aug 02, 2014

AmericanBankingNews.com

Citigroup Inc. Downgrades Eli Lilly and to Neutral

They currently have a $68.00 target price on the stock, up from their previous target price of $60.00.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, Eli Lilly, Imclone Systems, Healthcare Industry

Fri Aug 01, 2014

AmericanBankingNews.com

Eli Lilly and Given New $60.00 Price Target at Morgan Stanley

Morgan Stanley's price objective would suggest a potential downside of 1.12% from the stock's previous close.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, Eli Lilly, Imclone Systems, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••